<i>cpx-1</i> mutants display defective locomotion and increased body curvature. by Ya Wang (1202)

Ependymal flow is significantly slower at high glucose concentrations. by Francisco Nualart (231550)

Release comparison with model results. by Zahra Nazari (17102164)

“…All treatments evaluated using Duncan’s test at a significance level of 5%. Double-layer emulsions stabilized with pectin showed the highest viscosity and the lowest release of crocin in simulated stomach and intestine conditions. …”

Table indicating whether a risk factor showed a significant association with complicated grief for any time point in the study. by Emma A. M. Sanderson (12225310)

Induction and validation of NETs release by human and murine neutrophils. by Andreas Conforti (7446896)

Depletion of putative SDH subunits leads to decreased SDH activity and oxygen consumption. by Mariana F. Silva (10219520)

Point cloud fusion instance effect. by Hongliang Zou (20707270)

Subjects:

Numerical data points underlying presented graphs. by Luke R. Joyce (12107297)

Neutrophil activation and subsequent release of NE depends on pneumococcal virulence factor pneumolysin. by Lena Ostermann (16617850)

Subjects:

Change in the levels of parental stressors or rewards between time point 1 and time point 2. by Ragnhild Bjørknes (4908577)

Subjects:

F-actin and CD63 co-localization associates with increased MPO release in SCD neutrophils. by Emilia Alina Barbu (8174052)

“…Degranulation response was assayed in terms of MPO ng/ml plasma (upper panel), or fold increase over healthy neutrophils (lower panel). Data presented as dot plots±S.D., significance calculated with an unpaired Mann-Whitney test.…”

Patient demographic information at four time points. by Ruitian Song (11045127)

Subjects:

Study design. by Rieko Kondo (10010647)

Subjects:

RSV infection enhances HDM-induced release of IL-33. by Lydia Labrie (21755916)

Podocyte numbers in control and iPLA₂γ KO mice (WT1-positive cells). by Andrey V. Cybulsky (4007012)

Subjects:

Summary of the earliest time point for significant WD-induced changes in NASH-associated markers. by Melinda H. Spooner (6551933)

“…The figure illustrates the earliest time point for a significant change in the marker abundance and whether the marker <b>Increased</b> or <b>Decreased</b> in response to the WD. …”

Significant differences between Th17-cell levels of dogs suffering from IVDH at all three sampling time points and in comparison with the healthy control group. by Annika Kämpe (11507012)

KO of iPLA₂γ attenuates development of albuminuria in STZ-induced diabetic nephropathy. by Andrey V. Cybulsky (4007012)

Subjects:

Primary and secondary efficacy end points (intention-to-treat population). by Benjamin R. Lewis (22279166)

DHA decreased cell viability in HepG3 cells. by Arlet Hernandez (12289155)